Rocket Lab delivered a breakout year in 2025, with consolidated revenue through the first nine months rising 39% to $422 million. Gross profit nearly doubled from $79 million to $140 million, while backlog expanded 56% to $510 million, providing multi-year visibility on launch and space systems contracts. Although still unprofitable, the company narrowed its third-quarter loss per share to $0.03 from $0.10 a year earlier, reflecting improved operating leverage across its launch business and spacecraft component divisions.

In a recent hydrostatic pressure trial, Rocket Lab intentionally pushed its Neutron Stage 1 tank to failure, resulting in a rupture designed to validate structural margins. The test structure and facilities sustained no significant damage, and a second tank is already in production. Rocket Lab’s engineering team is analyzing test data to assess any impact on the Neutron development timeline and will provide a detailed schedule update during its fourth-quarter 2025 earnings call in February.

On January 16, 2026, Morgan Stanley raised its rating on Rocket Lab from Equal Weight to Overweight and increased its price target to $105, the highest on Wall Street. The firm cited the company’s broadening service offerings—from small-satellite launches to in-house manufacturing of spacecraft components—and reinforced confidence in management’s ability to capture a growing share of the $20 billion small-launch market over the next five years.

Over the past three months, shares of Rocket Lab have surged approximately 50%, driven by a reported 10% sequential increase in fourth-quarter revenue and a 36% uplift in valuation metrics. Investors have been buoyed by a stronger-than-expected manifest of launch contracts and preliminary component orders for Neutron, while institutional interest remains high as the company positions itself as a vertically integrated space infrastructure provider.